Opportunity to Join Remote Research Study Led by UC San Francisco
Dr. Caroline Tanner, MD PhD is recruiting for a new clinical trial led by a team of Parkinson’s experts at UCSF in partnership with researchers from across the country. The goal of the study is to help people with Parkinson’s disease or parkinsonism maintain their independence by reducing the risk of hip fractures.
People with Parkinson’s disease or parkinsonism have a much higher risk of hip and other fractures. TOPAZ (Trial of Parkinson’s and Zoledronic Acid) will test if zoledronate, an FDA-approved medication for osteoporosis (thinning of the bone), can prevent fractures in people with Parkinson’s disease, whether or not they have osteoporosis.
You can safely participate in TOPAZ from the comfort of your home, as it is a completely remote study.
To be eligible, individuals must have Parkinson’s disease or another type of parkinsonism and be at least 60 years of age.
If you have any questions, please visit our study website TOPAZstudy.orgor email TOPAZ@ucsf.edu, or call us directly at (415) 317-5748
